Published in J Cell Biol on July 01, 1987
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J (2008) 1.97
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest (1992) 1.82
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol (1989) 1.59
Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest (1989) 1.46
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest (1994) 1.41
Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J Cell Biol (1990) 1.35
TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res (2006) 1.26
Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest (1997) 1.21
Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J Cell Biol (1988) 1.13
Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol (1988) 1.12
Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells. J Physiol (1992) 1.08
Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol (1988) 1.07
Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul (1990) 1.01
TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest (1994) 0.99
TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol (2009) 0.95
Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest (1996) 0.91
Cell density governs the ability of human bronchial epithelial cells to recognize serum and transforming growth factor beta-1 as squamous differentiation-inducing agents. Am J Pathol (1990) 0.87
Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr Eye Res (2008) 0.85
Cytokines and growth factors promote airway smooth muscle cell proliferation. ISRN Inflamm (2012) 0.81
Response of fibroblasts to transforming growth factor-β1 on two-dimensional and in three-dimensional hyaluronan hydrogels. Tissue Eng Part A (2012) 0.81
Cell cycle-dependent regulation of elastin gene in cultured chick vascular smooth-muscle cells. Biochem J (1995) 0.80
Inhibition of spermidine synthase gene expression by transforming growth factor-beta 1 in hepatoma cells. Biochem J (1997) 0.78
The proliferation of neointimal smooth muscle cells cultured from rabbit aortic explants 15 weeks after de-endothelialization by a balloon catheter. Int J Exp Pathol (1994) 0.76
Transcriptional activation of p21 by Tranilast is mediated via transforming growth factor beta signal pathway. Br J Pharmacol (2006) 0.75
Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings. Tissue Eng Part A (2016) 0.75
In silico characterization of cell-cell interactions using a cellular automata model of cell culture. BMC Res Notes (2017) 0.75
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
The biology of platelet-derived growth factor. Cell (1986) 7.17
The pathogenesis of atherosclerosis (second of two parts). N Engl J Med (1976) 5.48
Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci U S A (1982) 3.88
Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A (1986) 3.83
Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77
Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol (1981) 3.41
Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (1977) 3.25
Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A (1986) 2.93
Human vascular smooth muscle in culture. Growth and ultrastructure. Lab Invest (1975) 2.41
Developmentally regulated production of platelet-derived growth factor-like molecules. Nature (1984) 2.30
Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci U S A (1985) 2.28
Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A (1986) 2.20
Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A (1986) 2.10
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol (1985) 2.05
Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol (1983) 2.03
Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun (1986) 1.90
Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol (1984) 1.71
Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells. Cancer Res (1983) 1.66
Symposium on in vitro studies related to atherogenesis. Life histories of hyperplastoid cell lines from aorta and skin. Exp Mol Pathol (1973) 1.47
Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol (1985) 1.40
Carotid artery stenosis following endarterectomy. Arch Surg (1982) 1.30
Hormonal requirements for growth of arterial smooth muscle cells in vitro: and endocrine approach to atherosclerosis. Science (1981) 1.20
Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells. J Cell Biol (1984) 1.11
In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells. J Cell Physiol (1986) 1.06
Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells. J Biol Chem (1985) 0.89
Fibronectin inhibits morphological changes in cultures of vascular smooth muscle cells. J Cell Physiol (1982) 0.81
Role of basic fibroblast growth factor in vascular lesion formation. Circ Res (1991) 2.38
Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A (1986) 2.10
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol (1985) 2.05
Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest (1990) 1.73
Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol (1984) 1.71
Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem (1987) 1.62
Novel embryonic genes are preferentially expressed by autonomously replicating rat embryonic and neointimal smooth muscle cells. Circ Res (2000) 1.45
Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol (1995) 1.30
Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J Biol Chem (1989) 1.15
Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells. J Cell Biol (1984) 1.11
Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen. J Cell Biol (1985) 1.08
Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res (1994) 1.05
Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol (1995) 0.94
Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation. Am J Respir Cell Mol Biol (1996) 0.85
Ultrastructural characteristics of endothelial permeability in chronic hypertension. Hypertension (1982) 0.84
Static tension is associated with increased smooth muscle cell DNA synthesis in rat pulmonary arteries. Am J Physiol (1995) 0.83
Developmental regulation of perlecan gene expression in aortic smooth muscle cells. Matrix Biol (1996) 0.81
An ameloblastoma with myofibroblasts and intracellular septate junctions. Cancer (1980) 0.80
The ultrastructural localization of membrane ATPase in rat thin limbs of the loop of Henle. Histochemistry (1979) 0.79
Regulation of collagen biosynthesis. Heparin alters the biosynthetic phenotype of vascular smooth muscle cells. Ann N Y Acad Sci (1985) 0.78
Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. Mol Biol Cell (1997) 0.78
The bicellular and reflexive membrane junctions of renomedullary interstitial cells: functional implications of reflexive gap junctions. Am J Anat (1980) 0.77
Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature. Am J Respir Cell Mol Biol (1999) 0.77
Tropoelastin gene expression in individual vascular smooth muscle cells. Relationship to DNA synthesis during vascular development and after arterial injury. Circ Res (1996) 0.77
Endothelial alterations and colloidal carbon permeability in the peripheral vasculature of the spontaneously hypertensive rat. Exp Mol Pathol (1980) 0.75